• English
    • Welsh
  • English 
    • English
    • Welsh
  • Login
Search DSpace:
  • Home
  • Research at Cardiff Met
  • Library Services
  • Contact Us
View item 
  • DSpace home
  • Cardiff School of Sport and Health Sciences
  • Health and Risk Management
  • View item
  • DSpace home
  • Cardiff School of Sport and Health Sciences
  • Health and Risk Management
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Intratympanic glucocorticosteroid therapy for idiopathic sudden hearing loss: meta-analysis of randomized controlled trials

Thumbnail
View/open
Publisher's PDF (877.9Kb)
Author
Lai, Dan
Zhao, Fei
Jalal, Nasim
Zheng, Yun
Date
2017-12-01
Acceptance date
2017-11-09
Type
Article
Publisher
Lippincott, Williams and Wilkins
ISSN
0025-7974
1536-5964 (ESSN)
Metadata
Show full item record
Abstract
Background and objective: Glucocorticoids are the standard treatment for idiopathic sudden sensorineural hearing loss (ISSNHL), but whether intratympanic or systemic therapy is superior remains controversial. Previous meta-analyses of this question have omitted key clinical trials or included observational studies. Methods: English-language randomized controlled trials in OVIDSP, PUBMED, EMBASE, CINAHL and the Cochrane Library comparing intratympanic vs. systemic glucocorticoid therapy for ISSNHL were meta-analyzed using RevMan 5.3. The primary outcome of interest was improvement in pure tone average (PTA) threshold. Results: Six trials involving 248 patients receiving intratympanic steroids and 236 receiving systemic steroids were meta-analyzed. PTA thresholds were similar between the two groups at 3 months after therapy initiation (mean difference, 0.24; 95%CI -2.43 to 2.91, P=.86; I2= 54%, P=.07, random-effects model). PTA thresholds were also similar at 6 months (mean difference, 4.69, 95%CI -5.84 to 15.22, P =.38), although the results showed extremely high heterogeneity (I2= 98%). Sensitivity analysis indicated that a single trial containing 250 patients provided the strongest evidence for equivalence between the two types of therapy. Rates of recovery within 3 months (defined as PTA improvement >10 dB) were similar between the two types of therapy(OR 0.92, 95%CI 0.59 to 1.43, P=.70), with no significant heterogeneity in the pooled data (I2=1%, P=.40). Conclusion: Intratympanic and systemic steroids therapies appear to show similar short-term efficacy for restoring hearing in patients with ISSNHL. Intratympanic therapy may reduce systemic side effects associated with steroid use.
Journal/conference proceeding
Medicine;
Citation
Lai, D., Zhao, F., Jalal, N. and Zheng, Y. (2017) Intratympanic glucocorticosteroid therapy for idiopathic sudden hearing loss: Meta-analysis of randomized controlled trials. Medicine, 96(50), p.e8955.
URI
http://hdl.handle.net/10369/9195
DOI
http://dx.doi.org/10.1097/MD.0000000000008955
Description
This article was published in Medicine in December 2017 available open access at http://dx.doi.org/10.1097/MD.0000000000008955
Rights
https://creativecommons.org/licenses/by/4.0/
Collections
  • Health and Risk Management [392]

Related items

Showing items related by title, author, subject and abstract.

  • Thumbnail

    A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program—AIM-HY INFORM trial 

    Mukhtar, O.; Cheriyan, J.; Cockcroft, John R.; Collier, D.; Coulson, J.M.; Dasgupta, I.; Faconti, L.; Glover, M.; Heagerty, A.M.; Khong, T.K.; Lip, G.Y.; Mander, A.P.; Marchong, M.N.; Martin, U.; McDonnell, Barry (Elsevier, 2018-05-20)
    Background Ethnicity, along with a variety of genetic and environmental factors, is thought to influence the efficacy of antihypertensive therapies. Current UK guidelines use a “black versus white” approach; in doing ...
  • Thumbnail

    Validity and Reliability of Surface Electromyography Measurements from a Wearable Athlete Performance System 

    Lynn, Scott; Watkins, Casey; Wong, Megan; Balfany, Katherine; Feeney, Daniel (University of Uludag, 2018-05-14)
    The Athos ® wearable system integrates surface electromyography (sEMG ) electrodes into the construction of compression athletic apparel. The Athos system reduces the complexity and increases the portability of collecting ...
  • Thumbnail

    Medical Terminations of Pregnancy: A Viable Source of Tissue for Cell Replacement Therapy for Neurodegenerative Disorders 

    Torres, Eduardo; Kelly, Claire; Harrison, A. W.; Williams, D.; Weyrauch, U. M.; Lane, E. L.; Kemp, P. J.; Scherf, Caroline; Precious, Sophie; Allen, Nicholas; Penketh, Richard; Amso, Nazar; Dunnett, Stephen; Rosser, Anne (Cognizant Communication Corporation, 2011)
    "Proof-of-principle" that cell replacement therapy works for neurodegeneration has been reported, but only using donor cells collected from fetal brain tissue obtained from surgical terminations of pregnancy. Surgical ...

Browse

DSpace at Cardiff MetCommunities & CollectionsBy issue dateAuthorsTitlesSubjectsThis collectionBy issue dateAuthorsTitlesSubjects

My Account

Login

Statistics

Most Popular ItemsStatistics by CountryMost Popular Authors

DSpace software copyright © 2002-2015  DuraSpace
Contact us | Send feedback | Administrator